Renato Thomas

706 total citations
15 papers, 464 citations indexed

About

Renato Thomas is a scholar working on Oncology, Cancer Research and Dermatology. According to data from OpenAlex, Renato Thomas has authored 15 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 6 papers in Cancer Research and 4 papers in Dermatology. Recurrent topics in Renato Thomas's work include Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (6 papers) and Neutropenia and Cancer Infections (5 papers). Renato Thomas is often cited by papers focused on Cancer Treatment and Pharmacology (10 papers), Breast Cancer Treatment Studies (6 papers) and Neutropenia and Cancer Infections (5 papers). Renato Thomas collaborates with scholars based in Italy, Russia and United Kingdom. Renato Thomas's co-authors include Giuseppe D’Aiuto, Gerardo Botti, Paolo Vallone, Massimo Rinaldo, Paolo Delrio, Francesco Izzo, Steven A. Curley, Takashi Tsuruo, Silvana Del Vecchio and Marco Salvatore and has published in prestigious journals such as Cancer, Breast Cancer Research and Treatment and European Journal of Nuclear Medicine and Molecular Imaging.

In The Last Decade

Renato Thomas

15 papers receiving 445 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Renato Thomas Italy 10 229 156 147 96 79 15 464
Lennart Bergqvist Sweden 10 159 0.7× 72 0.5× 76 0.5× 73 0.8× 37 0.5× 18 394
Zeynep Burak Türkiye 9 105 0.5× 82 0.5× 171 1.2× 74 0.8× 21 0.3× 28 371
Christina Kaiser Germany 11 143 0.6× 89 0.6× 148 1.0× 38 0.4× 44 0.6× 25 401
Ning-Ning Lu China 10 182 0.8× 57 0.4× 58 0.4× 152 1.6× 14 0.2× 54 350
Vanessa Heinrich Germany 11 109 0.5× 79 0.5× 126 0.9× 33 0.3× 69 0.9× 25 341
Jean-Rémy Garbay France 11 186 0.8× 310 2.0× 120 0.8× 140 1.5× 33 0.4× 20 604
Martín Velasco Spain 14 209 0.9× 423 2.7× 389 2.6× 316 3.3× 29 0.4× 24 816
Varol Çelik Türkiye 12 91 0.4× 138 0.9× 56 0.4× 191 2.0× 18 0.2× 34 431
V. Barbounis Greece 15 231 1.0× 85 0.5× 18 0.1× 71 0.7× 12 0.2× 31 481
Shicha Kumar United States 10 128 0.6× 149 1.0× 20 0.1× 109 1.1× 16 0.2× 38 319

Countries citing papers authored by Renato Thomas

Since Specialization
Citations

This map shows the geographic impact of Renato Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renato Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renato Thomas more than expected).

Fields of papers citing papers by Renato Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renato Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renato Thomas. The network helps show where Renato Thomas may publish in the future.

Co-authorship network of co-authors of Renato Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Renato Thomas. A scholar is included among the top collaborators of Renato Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renato Thomas. Renato Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Petrillo, Antonella, Mario Petrillo, Franco Fulciniti, et al.. (2011). Primary Phyllodes Tumor of the Axilla: DCE-MRI Findings with 1.5T Breast-Dedicated System and Pathological Correlation. The Breast Journal. 17(5). 525–527. 8 indexed citations
2.
Nuzzo, Francesco, Alessandro Morabito, Adriano Gravina, et al.. (2011). Effects on quality of life of weekly docetaxel-based chemotherapy in patients with locally advanced or metastatic breast cancer: results of a single-centre randomized phase 3 trial. BMC Cancer. 11(1). 75–75. 10 indexed citations
3.
Thomas, Renato, et al.. (2009). Comparing the cost of adjuvant anastrozole with the benefits of managing less patients with relapsed breast cancer. Breast Cancer Research and Treatment. 117(2). 289–295. 6 indexed citations
4.
Nuzzo, Francesco, Alessandro Morabito, Ermelinda De Maio, et al.. (2007). Weekly docetaxel versus CMF as adjuvant chemotherapy for elderly breast cancer patients: Safety data from the multicentre phase 3 randomised ELDA trial. Critical Reviews in Oncology/Hematology. 66(2). 171–180. 20 indexed citations
5.
Frasci, G., Giuseppe D’Aiuto, Renato Thomas, et al.. (2005). Biweekly Docetaxel-Irinotecan Treatment with Filgrastim Support Is Highly Active in Antracycline-Paclitaxel-Refractory Breast Cancer Patients. Oncology. 68(4-6). 391–397. 15 indexed citations
6.
Frasci, G., Pasquale Comella, Renato Thomas, et al.. (2004). Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study. Cancer Chemotherapy and Pharmacology. 53(1). 25–32. 10 indexed citations
7.
Frasci, G., Pasquale Comella, Renato Thomas, et al.. (2003). Biweekly docetaxel-irinotecan with filgrastim support in pretreated breast and non-small-cell lung cancer patients. A phase I study. Cancer Chemotherapy and Pharmacology. 53(1). 25–32. 14 indexed citations
8.
Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (2002). A Phase I–II Study on a Gemcitabine-Cyclophosphamide-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients. Oncology. 62(1). 25–32. 8 indexed citations
9.
Izzo, Francesco, Renato Thomas, Paolo Delrio, et al.. (2001). Radiofrequency ablation in patients with primary breast carcinoma. Cancer. 92(8). 2036–2044. 173 indexed citations
10.
Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (2001). Gemcitabine/Cyclophosphamide/5-Fluorouracil/Folinic Acid Triplet Combination in Anthracycline- and Taxane-Refractory Breast Cancer Patients: A Southern Italy Cooperative Oncology Group Phase I/II Study. Seminars in Oncology. 28(3 Suppl 10). 50–56. 4 indexed citations
11.
Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (2000). Cisplatin–epirubicin–paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study. Breast Cancer Research and Treatment. 62(2). 87–97. 18 indexed citations
12.
Frasci, G., Giuseppe D’Aiuto, Pasquale Comella, et al.. (1999). Cisplatin–epirubicin–paclitaxel weekly administration in advanced breast cancer: A phase I study of the Southern Italy Cooperative Oncology Group. Breast Cancer Research and Treatment. 56(3). 237–250. 15 indexed citations
13.
Frasci, G., Pasquale Comella, Giuseppe D’Aiuto, et al.. (1998). Weekly paclitaxel-cisplatin administration with G-CSF support in advanced breast cancer. A phase II study. Breast Cancer Research and Treatment. 49(1). 13–26. 23 indexed citations
14.
Lastoria, Secondo, et al.. (1997). Scintimammography (Smm) with 99mTc-Mdp: An Overview of the Experience at the National Cancer Institute of Napoli. Tumori Journal. 83(2). 515–519. 7 indexed citations
15.
Vecchio, Silvana Del, Andrea Ciarmiello, Maria Vincenza Carriero, et al.. (1997). In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients. European Journal of Nuclear Medicine and Molecular Imaging. 24(2). 150–159. 133 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026